TAKEDA PHARMACEUTICALS INTERNATIONAL AG
Last company where he held a position
TIGENIX SA Socio único
The most recent update in the BORME was on July de 2019. Takeda Pharmaceuticals International Ag was appointed as Socio único.
This company has its headquarters in Madrid and undertakes its business in the biotechnological research and development... sector.
Featured product:
Director profile
/ without VAT
The report contains
- Executive summary
- Position and company details